Invizyne Technologies Inc. (NASDAQ:IZTC - Get Free Report) was down 1.3% during mid-day trading on Thursday . The company traded as low as $9.60 and last traded at $9.75. Approximately 1,335 shares were traded during trading, a decline of 96% from the average daily volume of 37,647 shares. The stock had previously closed at $9.88.
Invizyne Technologies Trading Down 1.3%
The stock has a fifty day moving average of $12.51 and a 200-day moving average of $13.85.
Hedge Funds Weigh In On Invizyne Technologies
A number of hedge funds and other institutional investors have recently made changes to their positions in IZTC. Geode Capital Management LLC purchased a new position in shares of Invizyne Technologies during the fourth quarter worth about $277,000. BNP Paribas Financial Markets purchased a new position in shares of Invizyne Technologies during the fourth quarter worth about $35,000. Finally, Citadel Advisors LLC purchased a new position in shares of Invizyne Technologies during the fourth quarter worth about $456,000.
About Invizyne Technologies
(
Get Free Report)
Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Invizyne Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Invizyne Technologies wasn't on the list.
While Invizyne Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
